Dihydroquercetin (DHQ), widely known in the scientific community as Taxifolin, represents a pinnacle of natural antioxidant evolution. Derived primarily from the wood of the Siberian Larch (Larix sibirica), this bioflavonoid has transcended its origins to become a critical component in the global health and wellness economy.
As a leading ODM Dihydroquercetin powder supplier, we recognize that the industry is currently shifting toward high-purity, bioavailable formats. The global market is projected to see a CAGR of over 7.5% through 2030, driven by the increasing demand for "Information Gain" in clinical research—specifically regarding Taxifolin's role in cardiovascular health, capillary stabilization, and metabolic support. Our manufacturing processes are aligned with these macro trends, ensuring that our partners receive ingredients that are not just compliant, but market-leading.
How Dihydroquercetin Empowers Diverse Sectors
Taxifolin acts as a potent P-vitamin agent. We provide ultra-pure powder for the formulation of drugs aimed at reducing blood viscosity, improving capillary permeability, and protecting the hepatic system from oxidative stress.
Leveraging its high thermal stability, our ODM Dihydroquercetin is ideal for fortifying juices, dairy, and confectionery. It serves both as a health-booster and a natural preservative, extending shelf-life by preventing lipid peroxidation.
In the "Clean Beauty" sector, Taxifolin is prized for its ability to inhibit melanin synthesis and protect skin from UV radiation. Our fine-mesh powder ensures seamless integration into premium anti-aging creams and serums.
Benefiting from the solid foundation provided by its parent company, Xi'an Tianben Bioengineering Co., Ltd., Botanical Cube Inc. focuses on researching, developing, producing and selling healthy natural ingredients. With more than two decades of industry experience, it has become a leader in the field, specializing in providing high-quality plant extracts and customized solutions to global customers.
Our operations are supported by three companies - Xi'an Tianben Bioengineering Co., Ltd., Botanical Cube Inc. and Shaanxi Tianben Kangyuan Biotechnology Co., Ltd. - which together operate 3 production bases covering more than 100 acres and process more than 3,000 tons of plant raw materials each year. We export to 60% of the world's countries, serving more than 500 customers from all walks of life.
Established in 2012, our Sanyuan facility represents the heart of our technical refinement. Here, we specialize in the extraction of flavonoids like Dihydroquercetin using proprietary low-temperature extraction technology to preserve molecular integrity.
Powder collection, crushing and sieving, mixing and drying processes are all performed in a Class 100,000 cleanroom environment. Our operators strictly follow hygiene protocols and wear sterile gowns, masks and gloves to maintain product purity and safety.
Bridging the Gap Between Quality and Regulation
We provide full documentation support including COA, MSDS, HPLC testing reports, and Stability Data. Our Dihydroquercetin meets the stringent standards of EFSA (EU), FDA (USA), and TGA (Australia).
With localized warehousing partnerships in Europe and North America, we offer "Just-In-Time" delivery, mitigating the risks of global logistics volatility.
Not just a manufacturer, but a partner. We offer ODM services to adjust particle size (mesh), solubility (water-soluble vs. fat-soluble), and blend ratios with synergistic ingredients like Vitamin C and Resveratrol.
The future of Dihydroquercetin manufacturing lies in bioavailability enhancement. Our R&D team is currently focused on two primary technological frontiers:
By 2026, we aim to introduce a 99.9% pharmaceutical-grade Taxifolin specifically designed for IV-injectable formulations, expanding the therapeutic horizon of this incredible molecule.
Botanical
